Heidelberg Pharma AG (ETR:HPHA) | Finanzwire

Basculer en Français

9821	Companies
197095	Keywords
128171	Articles
104822	Press releases

Home
Companies
Heidelberg Pharma AG

BRIEF

published on 03/21/2025 at 07:12, 10 months 18 days ago

Heidelberg Pharma Reports 2024 Financial Results and Clinical Progress

Clinical Trials Heidelberg Pharma ADC Technology Multiple Myeloma 2024 Financial Results
PRESS RELEASE

published on 03/21/2025 at 07:07, 10 months 18 days ago

Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
Heidelberg Pharma AG reports successful business performance in 2024 with improved financial figures including clinical trial results for HDP-101 in multiple myeloma and upcoming study for HDP-102. Financial outlook and strategy for 2025 highlighted

Financial Results Clinical Trial Heidelberg Pharma AG 2025 Outlook ATAC Technology
BRIEF

published on 03/13/2025 at 07:35, 10 months 26 days ago

Heidelberg Pharma Adjusts Royalty Financing with HealthCare Royalty

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Financing TLX250-CDx
PRESS RELEASE

published on 03/13/2025 at 07:30, 10 months 26 days ago

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Heidelberg Pharma and HealthCare Royalty amend royalty financing agreement, providing for USD 20 million payment and extending cash runway into 2027

Amendment Heidelberg Pharma HealthCare Royalty Royalty Financing Cash Runway
BRIEF

published on 03/13/2025 at 00:36, 10 months 26 days ago

Heidelberg Pharma Modifies Royalty Financing with HealthCare Royalty

FDA Approval Heidelberg Pharma HealthCare Royalty Royalty Financing TLX250-CDx
PRESS RELEASE

published on 03/13/2025 at 00:31, 10 months 26 days ago

EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
Heidelberg Pharma amends royalty financing agreement with HealthCare Royalty, extending cash runway into 2027 for innovative ADC development. USD 20 million payment provided

Heidelberg Pharma HealthCare Royalty Royalty Financing ADC Development Cash Runway
BRIEF

published on 01/13/2025 at 08:22, 1 year ago

Heidelberg Pharma Advances HDP-101 in Phase I/IIa Study

HDP-101 Multiple Myeloma Phase I/IIa Study Antibody Drug Conjugates Clinical Advancement
PRESS RELEASE

published on 01/13/2025 at 08:17, 1 year ago

Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
Heidelberg Pharma advances into Cohort 7 with BCMA ATAC candidate HDP-101 targeting multiple myeloma, showing promising results and complete remission in Phase I/IIa study

Heidelberg Pharma Multiple Myeloma Phase I/IIa Study Complete Remission BCMA ATAC
BRIEF

published on 11/06/2024 at 10:07, 1 year 3 months ago

Heidelberg Pharma Reveals Promising Data on HDP-101 at ASH 2024

Clinical Data Heidelberg Pharma HDP-101 ADC Technology Multiple Myeloma
PRESS RELEASE

published on 11/06/2024 at 10:02, 1 year 3 months ago

Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
Heidelberg Pharma AG to present promising new clinical data on lead ADC-candidate HDP-101 at ASH Annual Meeting 2024, showcasing potential for multiple myeloma treatment

Clinical Data HDP-101 Heidelberg Pharma AG ADC ASH Annual Meeting

Accesswire

Published on 02/07/2026 at 01:00, 1 day 9 hours ago

Green Bridge Metals Can Help Secure U.S. Production of Critical Mineral Titanium
Published on 02/06/2026 at 23:10, 1 day 11 hours ago

Topline Capital Management, LLC Announces Disposition of Shares of NamSys Inc.
Published on 02/06/2026 at 22:01, 1 day 12 hours ago

Totec Resources Announces Listing of Shares on the Frankfurt Stock Exchange and Adoption of Omnibus Incentive Plan
Published on 02/06/2026 at 15:30, 1 day 18 hours ago

Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 1 day 20 hours ago

Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange

View all ACCESSWIRE

EQS Group

Published on 02/07/2026 at 21:00, 13 hours 12 minutes ago

Alibaba Group Debuts 'Wonder on Ice,' an Immersive AI Experience at Milan’s Sforza Castle for Milano Cortina 2026
Published on 02/07/2026 at 16:35, 17 hours 37 minutes ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies
Published on 02/07/2026 at 16:20, 17 hours 52 minutes ago

NOTICE OF SETTLEMENT APPROVAL HEARING - SHORT FORM - WAYLAND GROUP CORP., SCOTT LANGILLE, GERHARD MÜLLER, PAUL PATHAK, ERIC SILVER, MICHAEL STEIN, JOHN DOES 1-3, CANACCORD GENUITY CORP., AND RF SECURITIES CLEARING LP (FORMERLY KNOWN AS GMP SECU
Published on 02/06/2026 at 19:25, 1 day 14 hours ago

Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 1 day 16 hours ago

EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG

Les Echos

Published on 02/06/2026 at 18:22, 1 day 15 hours ago

Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 1 day 18 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/05/2026 at 19:24, 2 days 14 hours ago

Minutes of the Combined General Meeting
Published on 02/05/2026 at 18:24, 2 days 15 hours ago

LNA SANTE : 2025 annual sales
Published on 02/05/2026 at 18:06, 2 days 16 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 January 2026

View all LES ECHOS COMFI WIRE